Day: August 22, 2022

VANCOUVER, British Columbia, Aug. 22, 2022 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today reported the Company’s consolidated interim financial results for the third quarter ended June 30, 2022.Royalty revenue YTD of $1.15 million, representing annual growth of 55% in the high-margin royalty portfolio. First 10kW GMP unit was commissioned for the dehydration of premium cannabis products in New Zealand, expanding the use of REV™ across the legalized global cannabis industry. REVworx™ facility obtained Safe Quality Food Certification (“SQF”) as part of the strategy to provide advanced toll processing capabilities to the food industry.Consolidated Financial Performance:($ ‘000s) Three months ended June 30,   Nine months ended June 30,      2022     2021 Change%     2022     2021   Change%                   Revenues   5,554     7,351 (24%)     18,732     19,570   (4%)  Direct...

SHANGHAI, China, Aug. 22, 2022 (GLOBE NEWSWIRE) — Dada Nexus Limited (NASDAQ: DADA, “Dada” or the “Company”), China’s leading local on-demand delivery and retail platform, today announced its unaudited financial results for the second quarter ended June 30, 2022. Second Quarter 2022 HighlightsTotal net revenues in the second quarter were RMB2,281.1 million. Total Gross Merchandise Volume (“GMV”) of JDDJ for the twelve months ended June 30, 2022 was RMB54.6 billion, an increase of 68.9% year over year from RMB32.3 billion in the same period of 2021. Number of active consumers for the twelve months ended June 30, 2022 was 72.8 million, as compared with 51.3 million in the same period of 2021.“With trust from partners and strong digitalization capabilities, Dada is uniquely positioned in the changing consumption environment,”...

Q2 2022 revenue of $40.3 million, an increase of 157% over the same period in 2021. Q2 2022 gross margin of 31.0%1 compared to 35.5% in Q2 2021. Q2 2022 Adjusted EBITDA2 loss of $3.2 million compared to a loss of $0.6 million in Q2 2021. Net loss of $44.2 million during Q2 2022 driven by $33.0 million non-cash impairment charge, compared to loss of $6.6 million in Q2 2021. Strategic priorities include driving organic growth, further cost optimization and financial stability and prudent cash management. Strong customer momentum in core Enterprise Health Solutions division with several large multi-year contract wins representing $4.2 million in ARR closed in the second quarter. New contracts represent over 350 new customers within the quarter, adding to the network of 7,200 loyal clients that trust CloudMD to provide services to employees...

NEW YORK, Aug. 22, 2022 (GLOBE NEWSWIRE) — BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced its financial results for the six months ended June 30, 2022. Revenues for the six months ended June 30, 2022 and 2021 were $9,947,109 and $11,424,991, respectively. Compared with the same period in 2021, revenue decreased by $1,477,882, mainly due to the decrease in pharmaceutical sales of $3,615,357. Cost of revenues for the six months ended June 30, 2022 and 2021 were $7,263,179 and $8,867,894, respectively. The decrease primarily reflected the decrease in revenues of most of our principal operating subsidiaries. For the six months ended June 30, 2022 and 2021, the Company had a gross margin of 27% and 22.4%, respectively. For the six months ended June...